Skip to main content

Table 1 Patient characteristics.

From: Expression of ADAMs and Their Inhibitors in Sputum from Patients with Asthma

  Patients with asthma Control subjects
n 21 17
Mean age, years 34 (20–67) 29 (23–40)
Sex, M/F 16/5 7/10
FEV1, % predicted 88 (36–123) 92 (82–114)
FEV1, mL 3354 (1164–4920) 3670 (2430–4130)
PC20M, mg/mL 0.80 (0.3–6.2) ND
Atopy, n 18/21 0/17
Therapy 21 NT 17 NT
  1. Values are expressed as mean (range); PC20M is expressed as geometric mean (range), NT indicates not treated (short-acting β2 agonists on demand); ND, not done; PC20M, methacholine concentration inducing a 20% fall in FEV1.